CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Ordinary Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit	Total
Balances at Dec. 31, 2022	$ 1	$ 1,295,725	$ (15)	$ (853,911)	$ 441,800
Balances (in shares) at Dec. 31, 2022	65,227
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(55,353)			(55,353)
Repurchase of ordinary shares, net of transaction costs (in shares)	(5,158)
Employee share-based compensation expense		7,021			7,021
Issuance of restricted shares (in shares)	557
Repurchase of shares to satisfy tax withholding		(887)			(887)
Repurchase of shares to satisfy tax withholding (in shares)	(84)
Net unrealized gain on marketable securities			66		66
Net Income (Loss)				(22,088)	(22,088)
Balances at Mar. 31, 2023	$ 1	1,246,506	51	(875,999)	370,559
Balances (in shares) at Mar. 31, 2023	60,542
Balances at Dec. 31, 2023		1,122,164	(65)	(909,104)	$ 212,995
Balances (in shares) at Dec. 31, 2023	48,091				48,091
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(445)			$ (445)
Repurchase of ordinary shares, net of transaction costs (in shares)	(38)
Employee share-based compensation expense		5,229			5,229
Issuance of restricted shares (in shares)	658
Repurchase of shares to satisfy tax withholding		(1,271)			(1,271)
Repurchase of shares to satisfy tax withholding (in shares)	(145)
Net unrealized gain on marketable securities			24		24
Net Income (Loss)				(11,664)	(11,664)
Balances at Mar. 31, 2024		$ 1,125,677	$ (41)	$ (920,768)	$ 204,868
Balances (in shares) at Mar. 31, 2024	48,566				48,566